{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:00:40Z","timestamp":1790064040522,"version":"4.0.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.mehy.2019.01.007","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T18:52:53Z","timestamp":1547232773000},"page":"95-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Can immunization with Bacillus Calmette-Gu\u00e9rin (BCG) protect against Alzheimer\u2019s disease?"],"prefix":"10.1016","volume":"123","author":[{"given":"Ofer N.","family":"Gofrit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herve","family":"Bercovier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Y.","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irun R.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamir","family":"Ben-Hur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Greenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2019.01.007_b0005","series-title":"World Alzheimer Report 2016: Improving Healthcare for People Living With Dementia: Coverage, Quality and Costs Now and in the Future","author":"Prince","year":"2016"},{"key":"10.1016\/j.mehy.2019.01.007_b0010","unstructured":"alzimpact.org."},{"key":"10.1016\/j.mehy.2019.01.007_b0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.trci.2018.06.014","article-title":"Inflammation as a central mechanism in Alzheimer's disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement (NY)"},{"key":"10.1016\/j.mehy.2019.01.007_b0020","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/0886022X.2018.1456462","article-title":"Low-dose IL-2 expands CD4+ regulatory T cells with a suppressive function in vitro via the STAT5-dependent pathway in patients with chronic kidney diseases","volume":"40","author":"Li","year":"2018","journal-title":"Ren Fail"},{"key":"10.1016\/j.mehy.2019.01.007_b0025","doi-asserted-by":"crossref","first-page":"69347","DOI":"10.18632\/oncotarget.12469","article-title":"Neuroprotective effects of CD4+CD25+Foxp3+ regulatory T cells in a 3xTg-AD Alzheimer's disease model","volume":"7","author":"Baek","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.mehy.2019.01.007_b0030","doi-asserted-by":"crossref","first-page":"245","DOI":"10.3389\/fnagi.2018.00245","article-title":"Blood-cerebrospinal fluid barrier gradients in mild cognitive impairment and Alzheimer's disease: relationship to inflammatory cytokines and chemokines","volume":"10","author":"Ott","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.mehy.2019.01.007_b0035","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s40425-017-0280-z","article-title":"Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of bladder carcinoma","volume":"5","author":"Kamat","year":"2017","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.mehy.2019.01.007_b0040","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2249.1999.00756.x","article-title":"Systemic immune response after intravesical instillation of bacille Calmette-Gu\u00e9rin (BCG) for superficial bladder cancer","volume":"115","author":"Taniguchi","year":"1999","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.mehy.2019.01.007_b0045","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archneur.1997.00550230066019","article-title":"Education and other measures of socioeconomic status and risk of incident Alzheimer disease in a defined population of older persons","volume":"54","author":"Evans","year":"1997","journal-title":"Arch Neurol"},{"key":"10.1016\/j.mehy.2019.01.007_b0050","unstructured":"Whitmer R. Conference coverage, Type 1 Diabetes Increases Dementia Risk. Neurology Reviews. 2015; September; 23:25."},{"key":"10.1016\/j.mehy.2019.01.007_b0055","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41541-018-0062-8","article-title":"Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations","volume":"3","author":"K\u00fchtreiber","year":"2018","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.mehy.2019.01.007_b0060","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1212\/WNL.53.7.1588","article-title":"Use of Bacille Calmette-Gu\u00e8rin (BCG) in multiple sclerosis","volume":"53","author":"Ristori","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.mehy.2019.01.007_b0065","doi-asserted-by":"crossref","first-page":"6201","DOI":"10.4049\/jimmunol.181.9.6201","article-title":"Mycobacterium bovis bacille calmette-guerin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-\u03b3 -independent manner","volume":"181","author":"Lee","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.mehy.2019.01.007_b0070","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","article-title":"Multiscale analysis of independent Alzheimer's cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus","volume":"99","author":"Readhead","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2019.01.007_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2018.00324","article-title":"Corroboration of a major role for herpes simplex virus Type 1 in Alzheimer's disease","author":"Itzhaki","year":"2018","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.mehy.2019.01.007_b0080","first-page":"200","article-title":"Nonspecific immune stimulation with BCG in Herpes simplex recidivans. Follow-up 5 to 10 years after BCG vaccination","volume":"104","author":"Hippmann","year":"1992","journal-title":"Wien Klin Wochenschr"},{"key":"10.1016\/j.mehy.2019.01.007_b0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbd.2017.02.001","article-title":"Immunization with Bacillus Calmette-Gu\u00e9rin (BCG) alleviates neuroinflammation and cognitive deficits in APP\/PS1 mice via the recruitment of inflammation-resolving monocytes to the brain","volume":"101","author":"Zuo","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mehy.2019.01.007_b0090","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/brain\/awv408","article-title":"Beneficial effect of interleukin-2-based immunomodulation in Alzheimer-like pathology","volume":"139","author":"Dansokho","year":"2016","journal-title":"Brain"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718312155?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987718312155?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T05:13:28Z","timestamp":1606022008000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987718312155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":18,"alternative-id":["S0306987718312155"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2019.01.007","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can immunization with Bacillus Calmette-Gu\u00e9rin (BCG) protect against Alzheimer\u2019s disease?","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2019.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}